FDA delays decision on first drug to prevent HIV infection

   Jun 9, 4:37 pm

London, June 9 (ANI): US health regulators have delayed until mid-September a decision on whether to approve Truvada as the first pill that prevents HIV infection.

Drug maker Gilead Sciences said on Friday that the Food and Drug Administration (FDA) would take an additional three months to review its drug application, after the California Company submitted additional materials to the agency earlier this month.

In May, a panel of experts recommended approval of the daily pill for healthy people at high risk of contracting HIV, the Daily Express reported.

The group's vote is non-binding, but the FDA often follows its advice.

Gilead said that it had submitted updated details on its safety materials for patients and doctors using Truvada.

The FDA typically extends its reviews after receiving such information. (ANI)

Scientists warn Ebola virus has mutated Jan 29, 2:16 pm
London, Jan. 29 (ANI): Scientists tracking the Ebola outbreak in Guinea have recently stated that the virus has started to mutate, which might make it somewhat less deadly but more contagious eventually.
Full Story
Peanut allergy may soon be history Jan 29, 1:32 pm
Wellington, Jan. 29 (ANI): Researchers may have recently found a potential peanut allergy cure, it has been reported.
Full Story
Online dieters who make more 'connections' lose more weight Jan 29, 11:39 am
Washington, Jan. 29 (ANI): A new study has recently revealed that people who make more connections while using an online weight management program lose around more than 8 percent of their body weight in six months.
Full Story
How green tea rids you of oral cancer Jan 29, 10:53 am
Washington, Jan 29 (ANI): Green tea consists of an ingredient, which may help kill oral cancer cells, without touching the healthy cells, says a new research.
Full Story
Comments

LATEST STORIES
TOP VIDEO STORIES
PHOTO GALLERY